I agree the weak hands will unload some at first but at the same time this presents an awesome value.
Lets take a look at the facts:
FDA did not reject the study,
FDA did not require additional studies,
They only postponed their decision.
My opinion is FDA is willing to approve but with everything going on Washington, they are postponing everything.
But, still the PPS is an awesome value and most likely with double towards February.